Fabio Puglisi

15.9k citations
359 papers · 8.3k indexed · 2 hit papers · h-index 43

Fabio Puglisi

341 papers receiving 8.1k citations

Hit Papers

Phase III Study of Bevacizumab Plus Docetaxel Compared Wi...201020262015202020102011200400600

Peers

Fabio Puglisi
Comparison fields: 5 of 144
  • Oncology 4.8k
  • Cancer Research 2.5k
  • Pulmonary and Respiratory Medicine 2.4k
  • Molecular Biology 2.3k
  • Radiology, Nuclear Medicine and Imaging 971
Replace Henry Gómez with:
Henry Gómez Peru
Elżbieta Senkus Poland
Nicholas J. Robert United States
Henri Roché France
Maura N. Dickler United States
Edith P. Mitchell United States
David Khayat France
George Somlo United States
Rebecca Dent Singapore
P. Kelly Marcom United States
Fabio Puglisi relative to Henry Gómez Peru Henry Gómez's profile →
Citations per field
00.5×2.6×
Henry Gómez · 1×
Citations per year

Countries citing papers authored by Fabio Puglisi

Since Specialization
Citations

This map shows the geographic impact of Fabio Puglisi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabio Puglisi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabio Puglisi more than expected).

Fields of papers citing papers by Fabio Puglisi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabio Puglisi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabio Puglisi. The network helps show where Fabio Puglisi may publish in the future.

Co-authorship network of co-authors of Fabio Puglisi

This figure shows the co-authorship network connecting the top 25 collaborators of Fabio Puglisi. A scholar is included among the top collaborators of Fabio Puglisi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabio Puglisi. Fabio Puglisi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 2
5 18
6 1
7 7
8 7
9 15
10 32
11 4
12 3
13 7
14 29
15 7
16 62
17 12
18 12
19 1
20 57

About Fabio Puglisi

Fabio Puglisi is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 359 papers that have together received 8.3k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (80 papers), Breast Cancer Treatment Studies (78 papers) and Cancer Treatment and Pharmacology (77 papers). The work is most often cited by research in Oncology (4.8k citations), Cancer Research (2.5k citations) and Pulmonary and Respiratory Medicine (2.4k citations). Fabio Puglisi has collaborated with scholars based in Italy, United States and Ukraine. Frequent co-authors include Carla Di Loreto, Alessandro Marco Minisini, Lorenzo Gerratana, Giuseppe Damante, Luca Gianni, Mark X. Sliwkowski, C. Kent Osborne, Carlos L. Arteaga, Edith A. Perez and Lucia Del Mastro. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026